- Home
- LAZ vs IMVT Comparison
LAZ vs IMVT Comparison
Compare LAZ & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAZ
- IMVT
- Stock Information
- Founded
- LAZ 1848
- IMVT N/A
- Country
- LAZ United States
- IMVT United States
- Employees
- LAZ N/A
- IMVT N/A
- Industry
- LAZ Investment Managers
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LAZ Finance
- IMVT Health Care
- Exchange
- LAZ Nasdaq
- IMVT Nasdaq
- Market Cap
- LAZ 4.1B
- IMVT 3.4B
- IPO Year
- LAZ 2005
- IMVT N/A
- Fundamental
- Price
- LAZ $38.64
- IMVT $14.72
- Analyst Decision
- LAZ Hold
- IMVT Buy
- Analyst Count
- LAZ 7
- IMVT 10
- Target Price
- LAZ $46.83
- IMVT $40.14
- AVG Volume (30 Days)
- LAZ 1.6M
- IMVT 2.2M
- Earning Date
- LAZ 04-25-2025
- IMVT 05-28-2025
- Dividend Yield
- LAZ 5.18%
- IMVT N/A
- EPS Growth
- LAZ N/A
- IMVT N/A
- EPS
- LAZ 2.87
- IMVT N/A
- Revenue
- LAZ $2,932,289,000.00
- IMVT N/A
- Revenue This Year
- LAZ N/A
- IMVT $108.88
- Revenue Next Year
- LAZ $12.53
- IMVT N/A
- P/E Ratio
- LAZ $13.45
- IMVT N/A
- Revenue Growth
- LAZ 6.93
- IMVT N/A
- 52 Week Low
- LAZ $31.97
- IMVT $12.72
- 52 Week High
- LAZ $61.14
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- LAZ 47.61
- IMVT 41.22
- Support Level
- LAZ $33.45
- IMVT $14.01
- Resistance Level
- LAZ $40.22
- IMVT $15.17
- Average True Range (ATR)
- LAZ 2.53
- IMVT 1.15
- MACD
- LAZ 0.73
- IMVT 0.15
- Stochastic Oscillator
- LAZ 80.41
- IMVT 65.36
About LAZ Lazard Inc.
Lazard has a storied history that can be traced back to 1848. The company's revenue is fairly evenly split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily driven by equities (over 80% of assets under management), has an international focus, and targets institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).